Breaking News

Noumed Life Sciences invests in GEA MODUL Q tablet press technology

Noumed Life Sciences, an integrated generics pharmaceutical company that offers a wide range of services and a variety ...

Advent International to acquire Zentiva, Sanofi's European generics business

Advent to invest in Zentiva to create a new, independent European generics leader

Although the US dominates the biosimilar market, Brazil and South Korea are gaining a foothold

Biosimilars are becoming increasingly popular with pharmaceutical companies; however, knowing which markets have been ...

Slow and steady

Generic drugs find a growing position in the US pharma market

Pricing system reform and generics trend apparent at CPhI Japan 2018

After recent changes in Japan, which is known to be an innovative drug market, an increase in international generic API ...

Hospital-owned generics initiative unlikely to benefit the CMO industry

A recently-announced plan to establish a not-for-profit generic pharmaceutical company is unlikely to be a boon to the ...

The race to be first: drug delivery systems for biosimilars

For biosimilar manufacturers, the market potential is significant, especially for those that are first to market

Uhlmann helps enhance packaging capacity of CMO Surepharm Services

British pharmaceuticals CMO Surepharm Services has experienced streamlined productivity following its installation of ...

Sartorius Stedim Biotech launches chemistry testing services

Allows structural and functional analyses to be conducted in parallel to deliver a comprehensive data package for ...

Labelling and generics: who is accountable?

Bindu Narang, Director of Regulatory Affairs and Scientific Writing, Sciformix Corporation, considers the impact of ...

Time to address price hikes in US generic drugs

Generic drugs costs have climbed dramatically in recent years, hitting US patients and producers. Edward S. Price, PCI ...

Global generics market to experience double-digit growth through to 2021

America remains good for growth, whereas Europe lags behind even the UK, with its large generics market

Patent battle for Aloxi in the US

Helsinn Healthcare and Eisai fall foul of reversed court decision regarding Teva Pharmaceuticals and Aloxi patent for ...